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Abstract
Mosaic Analysis with Double Markers (MADM) is a method for generating genetically mosaic mice, in which sibling mutant
and wild-type cells are labeled with different fluorescent markers. It is a powerful tool that enables analysis of gene function
at the single cell level in vivo. It requires transgenic cassettes to be located between the centromere and the mutation in the
gene of interest on the same chromosome. Here we compare procedures for introduction of MADM cassettes into new loci
in the mouse genome, and describe new approaches for expanding the utility of MADM. We show that: 1) Targeted
homologous recombination outperforms random transgenesis in generation of reliably expressed MADM cassettes, 2)
MADM cassettes in new genomic loci need to be validated for biallelic and ubiquitous expression, 3) Recombination
between MADM cassettes on different chromosomes can be used to study reciprocal chromosomal deletions/duplications,
and 4) MADM can be modified to permit transgene expression by combining it with a binary expression system. The
advances described in this study expand current, and enable new and more versatile applications of MADM.
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Introduction
Genetically mosaic animals (genetic mosaics) contain cells with
different genotypes. Phenotypic analysis of genetic mosaics has
become an indispensible tool in modern genetics. Genetic mosaics
are usually created by using site-specific recombinases from
heterologous biological systems, most prominently including Cre
recombinase from the E. coli phage P1 [1] and Flp recombinase
from the S. cerevisiae 2 m plasmid [2]. DNA recombination can
occur either in cis (on the same chromosome) or in trans (between
chromosomes). Intrachromosomal recombination techniques usu-
ally rely on the presence of two recombination sites flanking a
particular DNA sequence that will be excised upon recombination
[3]. In contrast, interchromosomal recombination techniques
depend on recombination between chromatids after DNA
replication in the G2 phase of the cell cycle to generate sibling
cells of different genotypes. Interchromosomal recombination has
been used to develop various versions of mosaic analysis in fruit
flies [4,5,6,7,8,9]. The common and key feature of these
approaches is that they create cells with different genotypes in
vivo and at the same time label those cells with unique markers that
strictly correlate with the genotype. To enable such concomitant in
vivo genetic manipulation and labeling in mammals, we have
established Mosaic Analysis with Double Markers (MADM) in
mice (Figure 1A) [10]. We have used MADM since its inception
to perform lineage studies [11] and analyze gene function in a
number of biological processes including cell proliferation [12],
dendritic patterning [13], neuronal migration [14] and tumor
initiation and progression [15]. To expand the utility and
versatility of MADM, we present here modifications and new
applications of the technique, and compare different procedures
for establishment of MADM-ready chromosomes.
Results
Design of new MADM cassettes
The original version of MADM relied on the DsRed2
fluorescent protein as one of the two markers [10]. Due to the
low DsRed2 fluorescence signal in tests in vitro, six Myc epitope
tags were added to its C-terminus. The addition of these epitope
tags proved to be essential, because the detection of DsRed2
expression from knocked-in MADM cassettes in vivo required anti-
Myc immunostaining [10]. For the new MADM cassettes, we
chose tdTomato (tdT) over DsRed2, due to its improved
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33332brightness [16]. We also added three Myc epitope tags to its C-
terminus, and this addition did not appear to affect the tdT
fluorescence (data not shown).
The original MADM cassettes were designed to split two
fluorescent protein genes approximately in the middle of each
gene [10] (Figure 1B, left). To replace one fluorescent protein
gene with another (e.g., DsRed2 with tdT), an entirely new set of
cassettes needs to be constructed, as neither of the existing cassettes
would be compatible with any new cassette. We therefore aimed to
create a more flexible design for new cassettes, such that one of
them would be compatible with any new cassette and could be
subsequently reused. In our new design for splitting the red
fluorescent protein tdT, the first exon contains only the start
codon (Figure 1B, right). Therefore the two new cassettes are:
GFP
N-terminus-intron-tdT3Myc
ATG-less (for simplicity, GT) and ATG-
intron-GFP
C-terminus (for simplicity, TG). The new TG cassette is now
compatible with any GFP
N-terminus-intron-X
ATG-less (for simplicity, GX)
cassette, where X
ATG-less (for simplicity, X) is any gene without the
start codon (Figure 1B, bottom right). This design has been
especially useful for combining MADM with a binary expression
system to create MADM-Tet, where X is the tetracycline
transactivator tTA2 [17] without the start codon (for details see
below).
Expansion of MADM to additional chromosomes via
random transgenesis in ES cells
MADM requires two reciprocally chimeric marker genes
(‘MADM cassettes’, e.g., GT and TG), which are targeted into
Figure 1. The MADM principle and design of new MADM cassettes. A) MADM relies on two reciprocally chimeric marker genes (for example,
GR and RG, see part B below for cassette description) that have been knocked into the same locus on homologous chromosomes. Recombination in
the G2 phase of the cell cycle regenerates the functional marker genes on a pair of chromatids. X-segregation of chromatids (the recombinant
chromatids segregate to different cells) generates a red and a green cell. Z-segregation of chromatids (the recombinant chromatids congregate to
the same cell) generates a double-labeled (yellow) cell and an unlabeled cell. If a mutation (asterisk) is present distally to the GR cassette, the green
cells will be homozygous for the mutation. This orientation of the cassettes corresponds to MADM in the Rosa26 locus. If the cassettes are in the
opposite orientation with respect to the centromere, the genotypes for green and red cells will be inverted (for example in MADM-11). If mitotic
recombination occurs in G0 or G1, a double-labeled cell is produced without altering the genotype of the cell. B) The ‘‘old’’ MADM cassettes
contained two genes encoding fluorescent proteins (dsRed2 and GFP) split roughly in the middle. The ‘‘new’’ cassettes use the same GFP split, but
split the second gene (for example, tdTomato) into ATG and Gene
ATG-less. That way, the ATG-G
C-terminus (for simplicity, TG) becomes a universal cassette
that can be paired with any G-Gene
ATG-less cassette. The single white triangle represents a single loxP site, a combination of loxP sites or the loxP-
flanked (floxed) neomycin resistance gene (see Figure S1 for detailed description of MADM cassettes).
doi:10.1371/journal.pone.0033332.g001
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to study gene function, the MADM cassettes must be located
between the gene of interest and the centromere. This is because
only chromosomal segments distal to the recombination sites
within the MADM cassettes can undergo exchange and produce
homozygosity after X-segregation in the G2 phase of the cell cycle
(Figure 1A, top right). At present, only genes located on mouse
chromosome (Chr.) 6 distal to the Rosa26 locus and on Chr. 11
distal to the Hipp11 locus can be subjected to MADM [10,14]. To
extend the MADM technology to other genes in the mouse
genome, MADM cassettes need to be inserted into additional
chromosomes. One possibility is to employ random transgenesis to
obtain integrations throughout the mouse genome. However,
random transgene integration of one MADM cassette is in
principle not suited for subsequent repeated targeting of the
complementary cassette to the same locus. To overcome this
problem, we performed random transgenesis using convertible
precursor transgenes (pMADMa and pMADMb, Figure 2A, 2B)
that can be subsequently transformed into GT and TG MADM
cassettes.
pMADMa contains the ubiquitously active CA promoter and GT
and TG MADM cassettes flanked by FRT sites. After individual
integrants are isolated, they can be converted into GT or TG
cassettes by partial recombination catalyzed by the Flp recombi-
nase (Figure 2A). We screened ES cell clones to identify single-
copy, intact pMADMa transgenes integrated into intergenic
regions of the genome (for details see Methods). 25 out of ,190
ES clones had intact 59 and 39 ends of the transgene; 12 of them
were estimated to be single-copy based on Southern hybridization;
6 insertion sites were identified by using inverse PCR. Among
them, the location of one clone was confirmed to be within an
intergenic region, in a new locus we call Miya10 (M10), ,20 Mb
distal to the centromere of Chr. 10 (Figure 2C, blue triangle). To
obtain GT and TG transgenes, we introduced the Flp recombinase
into this ES cell clone. Among ,200 ES cell subclones, ten
subclones had partial recombination between the second and third
FRTs to convert pMADMa to GT, while only one subclone had the
reciprocal partial recombination between the first and the second
FRTs to generate TG. We established transgenic mouse lines from
these ES cells (hereafter called M10
TG and M10
GT) via standard
blastocyst injection to generate chimeras and subsequent germline
transmission of the transgenes.
As expected, mice transheterozygous for GT and TG in the Miya10
locus (M10
GT/TG) do not have colored cells in the absence of Cre-
mediated recombination (Figure 2D). When Nestin-Cre [18] or Hprt
Cre
[19] transgenes were separately introduced to create M10
GT/TG;Nestin-
Cre
+/2 or M10
GT/TG;Hprt
Cre/+ or M10
GT/TG;Hprt
Cre/Y,w eo b s e r v e d
cells labeled with GFP (green), tdTomato (red), or both (yellow), in
patterns predicted by Cre expression. For example, Nestin-Cre generates
MADM-labeled cells throughout the central nervous system, including
cortical pyramidal cells, interneurons, glia, hippocampal granule and
pyramidal cells (Figure 2D), and cerebellar Purkinje cells (data not
shown). Hprt
Cre allows the labeling of cells in the liver, heart, and small
intestine (Figure 2D) and all other tissues examined (data not shown).
When using the same Cre driver, labeling was qualitatively lessdense in
MADM-10 than in MADM-6 or MADM-11 (data not shown; ‘‘MADM-
number’’ refers to a genotype, where ‘‘MADM’’ signifies two reciprocal
cassettes in the same MADM locus combined with a Cre line, while the
number refersto a chromosome number).These data demonstrate that
random insertion-based transgenesis in ES cells can be used to establish
a functional MADM system in a new genomic locus.
However, the pMADMa-based approach had two limitations: 1)
The frequency of insertion of single copy transgenes was low
(,6%); 2) Partial recombination events to generate GT and TG
cassettes were highly biased in favor of GT (10:1), and therefore
obtaining the TG cassette became laborious. These limitations led
us to develop a second convertible precursor transgene, pMADMb.
pMADMb contains the CA promoter driving the bGeo marker (a
fusion of b-galactosidase and neomycin resistance gene), flanked
by non-compatible variants of FRT: wild-type FRT and FRT5
[20]. This transgene could be subsequently converted into any
other transgene, including a GT or TG cassette via Flp
recombinase-mediated cassette exchange [20] (Figure 2B). To
increase the chance of intact pMADMb integration, ‘protecting’
arms containing bacterial DNA were placed at the 59 and 39 ends
of the transgene (500 bp and 3.0 kbp, respectively). We electro-
porated pMADMb into mouse ES cells and isolated ,1000
subclones; 484 showed strong lacZ expression and 325 (,32%)
had intact 59 and 39 ends of the transgene. The intact transgene
frequency was ,2–3 fold higher for pMADMb than for pMADMa,
presumably due to the longer protection arms. We were able to
determine insertion sites for 161 clones using ‘‘splinkerette’’ PCR
[21]; 65 insertion sites were located in coding or intronic
sequences, and 96 were located in the intergenic areas (triangles
in Figure 2B). We confirmed the insertion sites by independent
genomic PCR for a subset of pMADMbtransgene insertions located
relatively close to corresponding centromeres (red triangles in
Figure 2B).
To test the Flp-mediated cassette exchange reaction in ES cells,
we selected one single-copy integrant located ,39 Mb from the
centromere of Chr. 1 in the Miya1 (M1) locus (Figure 2B) and
transfected it with a Flp recombinase plasmid and a plasmid
containing either the GT or TG cassette flanked with FRT5 and
FRT (see Methods). The cassette exchange efficiency was ,9% (5
out of 54 sub-clones) or 25% (12 out of 48 sub-clones) for GT or
TG cassettes, respectively. We established mice from these
converted ES cells (hereafter called M1
GT and M1
TG) via regular
blastocyst injection and chimeragenesis followed by the germline
transmission. Similarly to MADM-10, we observed Cre-dependent
labeling in conjunction with Nestin-Cre and Hprt
Cre (data not
shown). However, it is important to note that although the cellular
labeling obtained by MADM-1 and MADM-10 appears as
expected (red, green and yellow cells are all evident), this labeling
may not accurately report the cellular genotypes unless the loci are
biallelically and ubiquitously expressed (see below).
MADM expansion via targeted knock-in
Targeted knock-in [22,23] is a standard method for introducing
a transgene into a precise location in the mouse genome [24]. The
vast majority of ubiquitously expressed transgenes, including some
made in our lab [10,25], have been made via knock-in into the
Rosa26 locus [26]. To establish new MADM cassettes (GT and TG)
in a locus that has been already proven to support ubiquitous
expression, we inserted them into the Rosa26 locus. The knock-in
procedure into Rosa26 generated the GT and TG alleles that
allowed marker expression as described previously [10] (Figure 3,
S1). Single-labeled, green and red, cells and double-labeled,
yellow, cells were observed only when Cre was present in this
version of MADM-6 containing the new MADM cassettes
described above. As expected from in vitro cell culture tests, both
tdT and GFP fluorescence were visible without immunostaining
(Figure 3). Thus, this ‘new MADM-6’ is superior to the original
version of MADM-6 [10], which required immunostaining to
detect the red fluorescent protein.
To expand MADM to other chromosomes via targeted knock-
in, we aimed to select loci that should enable the majority of genes
on a particular chromosome to be subjected to mosaic analysis,
and that are likely to support ubiquitous and biallelic expression of
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33332Figure 2. Random integration-based approach to expand MADM to other mouse chromosomes. A and B) Schematic representations of
MADM precursor (pMADM) constructs. A) pMADMa contains the CA promoter, FRT-flanked MADM GT and TG cassettes and a single polyadenylation
signal (pA). The cassette containing the floxed neomycin phosphotransferase gene (loxP-pPGK-Neo-pA-loxP) is placed in the introns of both cassettes.
pMADMa can be converted into either GT or TG via partial Flp-mediated recombination in ES cells. B) pMADMb construct contains the CA promoter
driving the bgeo gene (a lacZ and neomycin-phosphotransferase fusion) flanked by FRT5 and FRT. pMADMb can be converted into any transgene,
including a GT or TG cassette via Flp- and FRT5/FRT-mediated cassette exchange in ES cells. These MADM cassettes contained a hygromicin resistance
gene (H) that was removed by QC31 integrase-mediated recombination (see Figure S1) before performing the experiments shown in D. C)
Distribution of pMADM transgene intergenic integration sites in the mouse genome. Each centromere is represented by a blue circle, and mapped
insertion sites are indicated by triangles (Mb, mega base pair). The pMADMa insertion site used to establish MADM-10 (Figure 2D) is represented by
the blue triangle located close to the centromere of Chr. 10. All the other triangles represent the insertion sites of pMADMb transgenes based on the
59 genomic sequence amplified by Splinkerette PCR. Insertion sites that were mapped close to centromeres, and were independently confirmed by
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to the centromere that are located between highly expressed genes
as judged by EST abundance [14]. As a specific example, we used
the above strategy to knock-in MADM cassettes into the Hipp11
locus on Chr. 11, and observed Cre-dependent labeling as
described [14] (Figure S1). We are in the process of generating
several other mouse chromosomes with inserted MADM cassettes
via the targeted knock-in approach described above.
Test for biallelic and ubiquitous marker expression
In order for MADM cassettes to reliably report cellular
genotypes, the locus containing the cassettes must support biallelic
expression in a cellular population of interest. Ideally, the locus
should also promote ubiquitous expression. To examine biallelic
expression of the new MADM cassettes in all loci examined in this
study, we generated the following alleles: GG (GFP
N-terminus-intron-
GFP
C-terminus) and TT (tdT3Myc
N-terminus-intron-tdT3Myc
C-terminus). Us-
ing the genetic scheme described in Figure 4A, we stimulated
interchromosomal recombination during meiosis independently in
the Hipp11, Miya1, Miya10 and Rosa26 loci to generate GG or TT
alleles in sperm or oocytes. In the process of generation of these
alleles, the floxed Neo was removed from the introns as confirmed
by PCR (data not shown). The newly generated alleles were then
transmitted to progeny to generate GG/+ and TT/+ animals for all
the loci. The frequency of progeny with GG or TT cassettes was
5.1% (4/78) for Rosa26, 15% (4/26) for Miya1, 17% (5/29) for
Miya-10, and 23% (8/35) for Hipp11, respectively. In these new
transgenes, the expression of GFP or tdT is driven by the CA
promoter, which should be ubiquitously active.
To test if a particular locus can indeed support biallelic
expression in various organs and cell types, we crossed GG and TT
mice from the same locus and examined labeling in various tissues.
If a locus can support biallelic and ubiquitous marker expression,
all cells should be double-labeled in an animal of the GG/TT
genotype. R26
GG/TT and H11
GG/TT appeared to support biallelic
and ubiquitous expression in all organs examined (Figure 4B).
Interpretation of the data for the brain is more complicated due to
the structure of neuronal tissue where many different cell types and
their processes are intermingled. We therefore focused on the
Purkinje cell layer of the cerebellum, where large Purkinje cell
bodies can be unambiguously defined. Indeed, all examined
Purkinje cells in R26
GG/TT and H11
GG/TT were double-labeled.
The same was observed for M10
GG/TT in the cerebellum Purkinje
cells and the heart (Figure 4B). However, M10
GG/TT in the liver
and M1
GG/TT in all examined organs showed highly mosaic
expression, displaying many unlabeled or single-labeled cells
(Figure 4B). Unlabeled cells likely represent biallelic silencing,
while single-labeled cells likely represent monoallelic expression/
silencing. These data indicate that the M1 locus does not provide
reliable marker expression, and that MADM-1 cannot be used for
phenotypic analysis since it does not guarantee 100% correlation
between genotype and marker expression. MADM-10 can be used
in heart and Purkinje cells, but biallelic expression must be tested
before application of this system to other cell populations. In
summary, the data observed for MADM-1 and MADM-10
underscore the importance of testing biallelic marker expression
from any new locus harboring MADM cassettes and for any
specific cell type before pursuing functional gene analysis.
Translocations and aneuploidy generated by MADM in
vivo
In addition to the interchromosomal recombination between
homologous chromosomes described above, MADM could, in
principle, mediate interchromosomal recombination between non-
homologous chromosomes. These recombination events could
generate uniquely labeled cells with reciprocal translocations, a
combination of partial trisomy and monosomy, or acentric and
dicentric chromosomes (Figure S2, 5A, 5C). Although Cre/LoxP-
mediated interchromosomal recombination between non-homol-
ogous chromosomes was previously demonstrated in mouse ES
cells [27,28] and in vivo [29,30,31,32], MADM could permit
unambiguous detection and distinction of cells with spatially and/
or temporally controlled translocation events by fluorescent
markers in vivo (Figure 5A, 5C).
To test the possibility of recombination between non-homolo-
gous chromosomes in vivo, we generated transgenic animals
containing MADM cassettes on non-homologous chromosomes
and a Cre recombinase transgene, and analyzed various tissues for
GFP and tdT expression. The genotype and labeling for a
particular combination of chromosomes depends on the orienta-
tion of MADM cassettes (Figure 5A, 5C). It is important to note
that in order for these strategies to accurately report cellular
genotypes, the loci carrying MADM cassettes need to support their
ubiquitous expression (at least at the tissue-wide level). As all our
analyses below include the M10 locus, we performed our tests in
the brain, where M10 appears biallelically and ubiquitously
expressed (see Figure 4B for the cerebellar Purkinje cells and data
not shown).
In animals in which the MADM cassettes are in the same
orientation on the centromere-to-telomere axis (e.g., R26
GT/+;
M10
TG/+;Hprt
Cre/+), double-labeled cells should contain a simple
reciprocal translocation. Single-labeled (green and red) cells should
exhibit abnormal copy numbers for parts of the chromosomes distal to
the loxP sites. For the particular combination of the R26 and M10
transgenes above, the red cells should be monosomic for the Chr. 6
portion and trisomic for the Chr. 10 portion, while the green cells
should be monosomic for the Chr. 10 portion and trisomic for the
Chr. 6 portion (Figure 5A). We observed both single- and double-
labeled cells in all tissues examined (nervous system, liver and small
intestine, Figure 5B). The majority of cells were double-labeled
(yellow) suggesting that most labeled cells were generated by post-
mitotic recombination (Figure S2A) [10]. Another contributing
factor to relative abundance of double-labeled cells could be the
differential survival of cells with different genotypes. At present, we
cannot distinguish between these possibilities.
Interestingly, in the olfactory epithelium, in which extensive
post-mitotic cell migration does not occur, we detected ‘‘twin-
spots’’ of adjacent green and red cells (Figure 5B). Moreover,
these single-colored cells were able to further divide several times
to form neighboring single-labeled clusters (Figure 5B and data
not shown). Because the overall labeling frequency was very low,
these red and green clusters most likely originated from a single
mitotic recombination event. These observations demonstrate that
MADM cassettes can be used to create uniquely labeled cells with
site-specific reciprocal translocations or aneuploidy in vivo.
Moreover, we show that cells with this type of aneuploidy are
viable and can even divide in vivo.
both 59 and 39 genomic PCR, are represented by red triangles. The insertion located ,39 Mb from the centromere of Chr. 1 (indicated by an asterisk)
was used to establish MADM-1. D) Representative epifluorescence images of tissue sections with genotypes indicated on top and tissue identity on
the bottom. The sections were unstained or stained only with DAPI to label nuclei (blue). The creation of fluorescent cells was Cre-dependent. Scale
bars, upper row of images: 100 mm, lower row: 50 mm.
doi:10.1371/journal.pone.0033332.g002
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orientation (e.g., M10
TG/+;H11
GT/+;Hprt
Cre/+), double-labeled cells
should contain an acentric and a dicentric chromosome. Single-
labeled cells should contain a dicentric or an acentric chromosome,
and also exhibit abnormal copy numbers: red cells should contain an
acentric chromosome and should be trisomic for the portion of Chr.
11 distal to loxP and monosomic for the portion of Chr. 10 proximal
to loxP; green cells should contain a dicentric chromosome and be
monosomic for the portion of Chr. 11 distal to loxP and trisomic for
the portion of Chr. 10 proximal to loxP (Figure 5C). We observed
both single- and double-labeled cells in various parts of the nervous
system (Figure 5D). Again, most of the cells were double-labeled,
and may have arisen postmitotically. It is important to note that in
this case, the recombinant chromosomes that produce labeling are
either dicentric or acentric. Unreliable transmission and loss of
dicentric and acentric chromosomes in mitosis may therefore result in
‘‘conversion’’ of double-labeled cells to single- or unlabeled cells.
Equivalent loss of acentric or dicentric chomosomes could convert
single-labeled cells into unlabeled cells. As double-labeled cells can be
generated both mitotically and postmitotically (Figure S2B), while
the single-labeled cellscan be generated only mitotically, the numbers
of single-labeled cells may be disproportionately decreased compared
to double-labeled cells due to the loss of dicentric and acentric
chromosomes during mitosis.
Figure 3. Targeted knock-in approach to create new Rosa26 MADM with GT and TG cassettes. A) Schematic representation of new alleles:
R26
GT and R26
TG. B), C) and D) Representative confocal images from tissues indicated on the bottom and genotypes indicated on top. Expected
labeling was observed only when Cre was present (compare B with C and D). Bright cellular labeling observed in C and D originates from native tdT
and GFP fluorescence (no additional immunostaining was performed). Some sections were stained with DAPI to label nuclei (blue). Scale bars, 50 mm.
doi:10.1371/journal.pone.0033332.g003
Figure 4. Test for global, biallelic expression from the newly modified MADM loci by creation of GG/TT transheterozygotes. A)
Mating scheme outlines the creation of GG and TT alleles via Cre-mediated meiotic recombination. The two new lines for each locus were crossed to
each other to generate the transheterozygous GG/TT animals. B) Representative confocal images of unstained tissue sections obtained from animals
with genotypes represented above. Cells or groups of cells, in which the expression of one marker is markedly higher than the expression of the
other, are indicated by asterisks. Scale bars, 100 mm.
doi:10.1371/journal.pone.0033332.g004
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Introduction of a binary expression system into MADM could
expand the scope and utility of the technique by permitting
expression of any transgene in one of the two mitotically generated
and uniquely labeled sibling cells. In addition, if a binary system can
be regulated, it would enable new types of analyses and enhance
their spatial and temporal resolution. These additional capabilities
could be used to: 1) rescue mutations with transgenes and test the
critical periods of gene function (mutation in gene X combined with
temporally-regulated expression of gene X); 2) test genetic
interactions (mutation in gene X and temporally-regulated expres-
sion of gene Y, or dominant negative gene Y); 3) test the effect of
gene overexpression; or 4) enable versatile subcellular labeling (e.g.,
synapse-specific labeling by expressing Synaptophysin-GFP fusion
protein to assess synaptic phenotypes) [33]. For example, the
inclusion of one or more binary expression systems in the similar
mosaic system in flies (Mosaic Analysis with a Repressible Cell
Marker, MARCM) [6] has greatly extended its utility [9,34].
The new design of MADM cassettes allowed us to reuse the TG
cassette for this purpose. In addition, we generated another new
cassette containing a split transcription factor, the tetracycline
transactivator, tTA2 [17]. Therefore, the two new cassettes for
MADM-Tet are: ATG-intron-GFP
C-terminus (TG)a n dGFP
N-terminus-
intron-tTA2
ATG-less (G-tTA2). The plasmids containing these cassettes
were tested in tissue culture to show that they express functional
GFP and tTA2 only in the presence of Cre (data not shown). We
knocked-inthenewG-tTA2cassetteintotheRosa26locus,andtested
it by creating a quadruple-transgenic mouse: R26
TG/G-tTA2;Nestin-
Cre
+/2;TRE-KZ
+/2 (Figure 6A). TRE-KZ, (originally called teto-
Kir2.1-IRES-tau-LacZ), is a random transgene encoding the
potassium channel Kir2.1 and a tau-LacZ fusion under the control
Figure 5. Cells with translocations and aneuploidy generated and labeled by MADM in vivo.A ) Schematic representation of cellular
genotypes generated by interchromosomal recombination between non-homologous Chr. 6 and Chr. 10. In both chromosomes, the MADM cassettes
are oriented in the telomere-to-centromere fashion. Each double-labeled cell contains the same reciprocal translocation, resulting in no net loss or gain
of DNA. Single-labeled (green and red) cells exhibit abnormal copy numbers for parts of the chromosomes distal to the loxP sites: red cells are
monosomic for the Chr. 6 portion and trisomic for the Chr. 10 portion; green cells have the reciprocal trisomy/monosomy. B) Representative confocal
imagesoftissuesectionsobtainedfromR26
GT/+;M10
TG/+;Hprt
Cre/Ymice.ThesectionswereunstainedorstainedonlywithDAPItolabelnuclei(blue,inthe
olfactory epithelium panel). The insets within the olfactory epithelium panel show examples of twin-spot labeling where red and green cells are located
inclose proximity.Duetotheoverall lowfrequencyoflabeling,each twin-spotlabelingmostlikelyoriginatedfroma singlemitotic recombinationevent.
Scale bars, panels: 100 mm, insets: 25 mm. C) Schematic representation of cellular genotypes generated by interchromosomal recombination between
non-homologous Chr. 10 and Chr. 11. The MADM cassettes are oriented differently in the two chromosomes with respect to the corresponding
centromeres. Eachdouble-labeledcellcontainsthereciprocal translocation,resultinginone acentricandone dicentricchromosome.Single-labeledcells
contain a dicentric or an acentric chromosome, and also exhibit abnormal copy numbers; the red cells are trisomic for Chr. 11 portion distal to loxP and
monosomicforChr. 10portionproximaltoloxP; thegreencells aremonosomicforChr. 11portiondistaltoloxPandtrisomicforChr. 10portionproximal
to loxP. D) Representative confocal images of unstained tissue sections obtained from M10
TG/+;H11
GT/+;Hprt
Cre/Y mice. Scale bars, 100 mm.
doi:10.1371/journal.pone.0033332.g005
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revealed the two antigens: the GFP signal (green) was distributed
throughout the cell, while the tau-LacZ signal (red) was predom-
inantly located in neuronal and glial processes (Figure 6B). Thus,
MADM-Tet enables a TRE transgene to be expressed in a subset of
MADM-labeled cells.
Discussion
MADM is a powerful tool for high-resolution mosaic analysis of
gene function in mice in vivo that requires MADM cassettes on the
chromosomes harboring genes of interest [10,12,13,14,15].
Therefore, to maximize the applicability of MADM to most genes
in the mouse genome, it would be ideal to establish MADM
cassettes near the centromeres of all mouse autosomes.
Here, we created new mice that harbor MADM transgenes on
different chromosomes, and compared two different methods for
introducing MADM cassettes into new loci. We also established a
test for biallelic and ubiquitous marker expression from these new
loci harboring MADM transgenes. Using this test, we observed
ubiquitous and biallelic expression from two targeted knock-ins,
but stochastic expression from two randomly introduced trans-
genes. At present, we cannot determine whether the stochastic
expression of the single-copy, randomly integrated transgenes is
due to the loci themselves or due to the fact that all randomly
integrated transgenes characterized in this study also contain
Figure 6. MADM-Tet combines MADM with a binary expression system. A) Schematic representation of MADM-Tet starting with the
following genotype: R26
TG/G-tTA2;Nestin-Cre
+/2;TRE-KZ
+/2. Although all cells contain the Nestin-Cre and TRE-KZ transgenes, for simplicity they are
displayed within the cells only when they are active. B) Confocal images of tissue sections stained with antibodies against GFP (green) and lacZ (red)
from mice of the genotype indicated above. Note that the two markers exhibit different subcellular distribution: GFP labels whole cells including
nuclei, whereas tau-lacZ is absent from the nuclei and labels the processes more strongly (an example of a red-only cell body is indicated by an
arrowhead). Scale bars, left and middle panels: 50 mm, right panel: 25 mm.
doi:10.1371/journal.pone.0033332.g006
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transgene ends. Our recent observations during the development
of a site-specific transgenesis technique show that bacterial DNA
can have a severe silencing effect, which is most prominent in the
liver [36]. The silencing effect of bacterial elements on
mammalian transgenes has been observed before in randomly
integrated transgenes [37] and episomal transgenes [38]. This
correlation suggests that the bacterial sequences flanking these
transgenes could contribute to their variable expression. There-
fore, targeted knock-ins or new random transgenesis screens,
where bacterial protection arms are avoided, should be the
methods of choice for expanding MADM cassettes onto other
chromosomes.
In the future, we recommend that new genomic loci harboring
MADM cassettes should be tested for biallelic expression by
creation of GG and TT alleles from GT and TG alleles (Figure 4A).
To expedite this key validation experiment, we recommend
creation of the GG allele before or in parallel to the GT and TG
alleles. The ubiquity of the expression in the new locus can then be
tested by examining the GG allele alone [10] or by crossing it to
R26
TT and assessing the extent of double-labeled cells for any cell
type of interest. However, the most rigorous test for biallelic
expression should finally be performed by crossing the GG and TT
alleles in the same locus as described in Figure 4.
Visual inspection of the efficiencies of MADM labeling
(including both single- and double-labeled cells) revealed that
H11.R26,M1.M10. For M10 and particularly M1, these
estimates are not completely reliable as these loci are not reliably
expressed. Nevertheless, these data suggest that homologous
recombination efficiencies differ quite widely for different
chromosomal loci in somatic cells in vivo, and they are consistent
with similar findings previously reported in embryonic stem cells
[39]. The expression levels of the marker genes driven by the same
pCA promoter in M10, H11 and R26 loci do not appear
dramatically different, at least in tissues in which the markers
are reliably expressed.
We also show that complementary MADM cassettes on
different chromosomes can be used to produce and label cells
that undergo various translocation events. This new application of
MADM now permits the analysis of single-cell phenotypes
produced by precisely defined translocation events in vivo.
Interestingly, in the M10/H11 translocation case, we observed
double-labeled Purkinje cells with elaborate dendritic trees,
suggesting that the presence of dicentric and acentric chromo-
somes does not perturb the development or maintenance of a
complex dendritic arbor. Systematic studies in the future can
determine the consequences of chromosomal aneuploidy on the
differentiation and function of different cell types.
Finally, we demonstrate that by replacing one of the fluorescent
markers with the tTA2 transcription factor, MADM can also
express a TRE-controlled transgene of interest in a small
population of cells. This capability can be used in the future to
combine transgene expression with loss-of-function mutations in
the same, uniquely labeled cells. Further modifications of the
technique would extend MADM-Tet capabilities. For example, a
new G-tTA2 cassette that would include labeling of tTA2-
expressing cells independently of the tTA2 activity would allow
their visualization before or after the expression of tTA-dependent
transgenes. Efficient generation of reliable TRE transgenes would
further facilitate the use of MADM-Tet. As a built-in TRE
transgene was mostly silent in the Rosa26 locus (as part of the G-
TET allele; Figure S1B and S3) and because TRE transgenes are
prone to silencing [40,41], we have been modifying the TIGRE T1
[42] locus to enable integrase-mediated site-specific transgenesis
[36] for efficient creation of reliable TRE transgenes. Together,
these advances enable new applications of MADM and will
facilitate additional extensions of MADM in the future.
Methods
Ethics Statement
All animal procedures were in compliance with the institutional
animal care guidelines and were approved by Stanford Uni-
versity’s Administrative Panel on Laboratory Animal Care (A-
PLAC, protocol number 14007).
Plasmid construction
Recombinant DNA was constructed using standard techniques.
When fragments were amplified by PCR, we used Phusion Taq
polymerase (Finnzymes), and confirmed the sequences fully by
DNA sequencing. All synthetic DNA fragments were also fully
confirmed by DNA sequencing.
pMADMa (pCA-FRT-G-Neo-T-FRT-T-Neo-G-FRT-pA).
pCA promoter (containing the chicken b-actin promoter and a
CMVenhancer)andtheSV40 polyadenylationsignal (pA)frompCA
(HZ2) [10], and synthetic DNA fragments containing FRT sites
were sequentially introduced into pBluescript to create a plasmid
intermediate, pKM3 (pCA-FRT-XmaI-EcoRI-FRT-SpeI-HindIII-FRT-
pA). The XmaI/EcoRI fragment of MADM-TG cassette [14] (see
construction details below) was introduced into a pBluescript vector
to flank this cassette with SpeI and HindIII. Then, the SpeI/HindIII
restriction fragment of MADM-TG cassette, and XmaI/EcoRI
fragment of MADM-GT cassette [14] were sequentially introduced
into pKM3 to generate pMADMa. The construct was digested with
restriction enzymes PvuI and AflIII, and the insert was gel-purified
using Qiagen gel extraction kit and eluted into 10 mM Tris-HCl,
pH 7.4, 0.1 mM EDTA. The purified and linearized DNA
contained ,50 bp and ,300 bp of vector sequence at its 59 and
39 ends, respectively. This vector sequence was deliberately retained
to minimize the transgene damage with exonucleases after
electroporation of the DNA into mouse ES cells.
pMADMb (pFRT5-pCA-bGeo-pA-pPGK-TK-pA-FRT). The
following fragments were assembled together in this order to make
pMADMb:
i) 59 protection arm: ,500 bp PCR fragment of b-lactamase
gene from pBluescript amplified by the following primers:
GGTACCATTTAAATAGATTATCAAAAAG-
GATCTTCACC and GGTACCTAACTCGCCTT-
GATCGTTGG.
ii) 319 bp PCR fragment of wheat germ agglutinin (WGA) gene
amplified by PCR primers: GGTACCGACGTGTCC-
CAACAACCACT and AAGCTTCATGCCACAG-
GATCCCCACT. This arm was placed immediately
downstream of the protection arm to provide unique
sequence in the mouse genome for the Splinkerette PCR.
Single NlaIII restriction site was artificially introduced in the
39 end of this arm for Splinkerette PCR.
iii) FRT5 (GAAGTTCCTATTCCGAAGTTCCTATTCTT-
CAAAAGGTATAGGAACTTC) from a synthetic DNA
was introduced after the unique 59 arm.
iv) pCA promoter from pCA (HZ2) [10].
v) SalI/KpnI fragment containing the bGeo gene from the
plasmid Z/EG [43].
vi) KpnI/HindIII fragment containing the pPGK-TK-pA cassette
from the plasmid pLOXPNT [24]. (Note that we eventually
decided not to use thymidine kinase (TK)-based selection.)
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TAGAAAGTATAGGAACTTC) from a synthetic DNA
was introduced after the TK cassette.
viii) 218 bp PCR fragment of yeast His3 gene amplified by PCR
primers GCGGCCGCTCGAAGTAGCCGCCGTTG-
TTGTTAT and GAGCTCGGTGATAGGTGG-
CAAGTGGT. (Note: This sequence was originally intro-
duced as a 39 unique area for screening purposes, but was
not used in this study.)
The construct was digested with restriction enzymes PvuI and
AflIII, and the insert was gel-purified using Qiagen gel extraction
kit and eluted into 10 mM Tris-HCl, pH 7.4, 0.1 mM EDTA.
The purified and linearized DNA contained ,500 bp and
,3000 bp of vector sequence at its 59 and 39 ends, respectively.
The vector sequences served as protection arms against endonu-
cleases after electroporation into the mouse ES cells.
pExG and pExT (pFRT5-pCA-GT-pA-FRT-attPx3-pPGK-Hyg-
pA-attB and pFRT5-pCA-TG-pA-FRT-attPx3-pPGK-Hyg-pA-attB):
Synthetic DNA fragments containing FRT5 [20,44] and FRT
were sequentially introduced 59 and 39 to the MADM cassettes in
the MADM-GT and TG constructs to generate intermediates
pFRT5-GT-FRT and pFRT5-TG-FRT. Independently, pattB-
Hyg-attPx3 was generated by flanking the hygromycin resistance
gene (Hyg) driven by the phosphoglyceratekinase promoter (pPGK)
with QC31 integrase recognition sites: three 70-bp long attP sites
from pBT298 [36] and a ‘‘full length’’ attB [45]. To create the final
constructs (pExG and pExT), the XmaI/BamHI fragment from
pattB-Hyg-attPx3 was introduced into the SwaI site of pFRT5-GT-
FRT and pFRT5-TG-FRT. The constructs were prepared by using
Endotoxin Free-Maxi prep (Qiagen) for the electroporation into
the mouse ES cells.
MADM cassettes
To construct and test final MADM targeting constructs we
created a set of constructs in the pCA (HZ2) plasmid, which
contains a polylinker between the pCA promoter (chicken b-actin
promoter and CMV enhancer) and an SV40 polyadenylation site
[10].
pCA-G-intron-T. The previously used first GFP exon from the
GR cassette [10] and tdT3Myc
ATG-less were assembled in pHZ2
separated by the previously described modified b-globin intron
containing BglII and loxP sites [10].
pCA-T-intron-G. The previously used second GFP exon from
the RG cassette [10] was assembled with a fragment containing a
Kozak sequence, ATG start codon and the same b-globin intron
desribed above in pHZ2.
pCA-G-intron
Neo-T and pCA-T-intron
Neo-G. We inserted a
BglII/BamHI fragment containing the neomycin resistance gene
(Neo) driven by an SV40 promoter and followed by the HSV TK
polyadenylation site into the BglII site of pCA-G-intron-T or pCA-T-
intron-G, respectively. We created three different versions of the Neo
cassette to contain different numbers or identities of recombination
sites: version 1: pLN: loxP-pSV40-Neo-pA; version 2:pFLN: FRT-loxP-
pSV40-Neo-pA; version 3: pFLLFLN: FRT-Lox5171-Lox2272-FRT-
loxP-pSV40-Neo-pA. The loxP versions, Lox5171 and Lox2272 are
incompatible with each other and with loxP, but each one is
compatible with itself [46]. They were introduced in attempts to
increase recombination efficiency. Comparisons of these intron
versions and their effect on recombination efficiency will be
described elsewhere (A. Henner and H. Zong, in preparation).
The intron versions that were used for creating targeting
constructs for particular loci described in this study are
schematically represented in Figure S1.
pBT234 (pCA-G-intron-tTA2
ATG-less-pA). Used for testing
the cassettes before the construction of final targeting constructs.
pBT250 (pCA-G-intron
Neo-tTA2
ATG-less-pA). pGLLFNL was
cloned into BglII site of pBT234.
pBT270 (pCA-G-intron
Neo-tTA2
ATG-less-pA-ii-TRE-
tdT3Myc-pA-ii). ii-TRE-tdT3Myc-pA-ii from pBT264 (pii-TRE-
tdT3Myc-pA-ii) [47] was inserted into pBT250.
Targeting constructs
All targeting constructs for the Rosa26 locus were created by
inserting a PmeI/AscI-digested fragment from a precursor plasmid
into the pROSA26-PA [48]. The pRosa26-GT precursor is pCA-G-
intron
Neo-T; pRosa26-TG precursor is pCA-T-intron
Neo-G;
pRosa26-G-tTA2 (pBT259) precursor is pBT250; pRosa26-
GTET (pBT272) prescursor is pBT270.
Control constructs
pBT255 (pCA-GFP4m). Used as a positive control for GFP
expression. GFP4m (or mut4EGFP) is a thermotolerant GFP
variant [49,50]. All other GFP-containing constructs in this study
contain this variant of GFP.
pCA-G-intron-G. Described originally in [10]. Used as a
positive control for split GFP expression.
pBT225 (pCA-tdT3Myc): Used as a positive control for tdT
expression and Myc staining.
pCA-ATG-intron-tdT. Constructed initially as a test for
splitting the tdT gene into an exon containing a start codon
(ATG) and and an exon containing the rest of tdT by the b-globin
intron containing the BglII site and loxP [10].
pBT224 (pCA-tTA2-pA). Used as a positive control for tTA2
activity in conjunction with pBT239 (TRE-tdT3Myc-pA) [47]. tTA2
gene was subcloned from pUHT61-1 [17].
pBT241 (pCA-ATG-intron-tTA2
ATG-less). Constructed ini-
tially as a test for splitting the tTA2 gene into ATG and the rest of
tTA2 by the b-globin intron. PCR was used to construct two DNA
fragments: XmaI-ATG-intron and tTA2
ATGless-EcoRI. The b-globin
intron was modified at the same position as described previously
[10] to contain single BglII, loxP and FRT sites. The two fragments
were ligated to each other (via blunt ends) and to BglII/EcoRI-
digested pCA (HZ2) [10] in a 3-way ligation reaction. This
construct was used to test the functionality of tTA2 after insertion
of the intron in conjunction with pBT239 (see above).
pBT267 (pCA-ATG-intron-tTA2
ATG-less-TRE-tdT3Myc-
pA) and pBT268 (pCA-ATG-intron-tTA2
ATG-less-iiTRE-
tdT3Myc-pAii). Constructed to compare the effect of insulators
on decreasing tTA2-independent activation of TRE. The con-
structs were also tested in the presence of doxycycline to assess
which construct has higher background expression of tdT3Myc.
Screening of ES cell clones obtained by random
transgenesis
We used standard techniques [24] to modify R1 mouse ES cells,
which originated from a 129 mouse strain [51].
pMADMa construct was introduced into ES cells via electropo-
ration, and individual G418-resistant clones were evaluated for
intact transgene integration by genomic PCR using primers KM1
(GTGCTGCAAGGCGATTAAGT) and KM2 (TTATG-
TAACGCGGAACTCCA) to detect the 59 end of each transgene
(PCR product, 211 bp), and CCCCCTGAACCTGAAACATA
and TGTGGAATTGTGAGCGGATA to detect the 39 end of
each transgene (PCR product, 275 bp). We further analysed the
genomic DNA from the ES cells containing intact transgenes by
Southern blotting. We used a probe for Neo, which is located in the
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the R26
TG/+ mouse line as a reference for a single-copy transgene.
For ES cells that contained single-copy transgenes based on the
Southern blot, we performed inverse PCR to identify the 59-
flanking genome sequence. Genomic DNA was digested with
restriction enzyme NlaIII and subjected to the ligase-mediated self-
ligation. The resultant circular DNA was then used as a template
for a two-step nested PCR to amplify the transgene flanking
region. For the first round of PCR, we used primers: TAATC-
GAAACCCTGGCGTTA and GTTTTCCCAGTCACGA-
CGTT. For the second round of PCR, we used 0.3 ml of the
first round PCR product and primers: ACTTAATCGCCTTG-
CAGCAC and TATAGGGCGAATTGGGGAAT. The final
PCR products were analyzed by electrophoresis, gel-extracted by
the Qiagen gel extraction kit, and analyzed by DNA sequencing.
For the intact single-copy transgenes integrated in intergenic
regions close to any centromere, we performed additional
Splikerette PCR [21] to confirm integration sites.
pMADMb was also introduced into R1 mouse ES cells by
electroporation and individual G418-resistant clones in 96-well
plates were evaluated for the expression of bgeo by lacZ staining.
96-well plates were washed with PBS, fixed by 0.2% glutaralde-
hyde in PBS for 5 min. at room temperature (RT), and washed 3
times at RT with the staining buffer (2 mM MgCl2, 0.01%
Deoxycholate, 0.02% NP40, 100 mM phosphate buffer, pH 7.5).
Cells were then treated with the solution containing: 5 mM
potassium ferricyanide (Sigma), 5 mM potassium ferrocyanide
(Sigma), 2.5 mM 5-bromo-4-chloro-3-indolyl-beta-D-galactopyra-
noside (X-gal, Invitrogen) at 37uC for 1-2 hours. We recorded the
activity of lacZ in individual clones and then extracted genomic
DNA from 96-well plates. We tested the intactness of 59 and 39
ends of the transgenes by PCR. We used the following primers:
CTATGCCCGAACAACCTCTG and ATCATATGCCAAG-
TACGCCC (for pMADMb 59 end); CCCCCTGAACCTGAAA-
CATA and ACCACTTGCCACCTATCACC (for pMADMb 39
end). The clones with high lacZ expression and intact transgenes,
were further analyzed by Splinkerette PCR [21] to identify the
flanking genomic sequence at the 59 end of the transgene.
Splinkerette PCR was reported to be more efficient than inverse
PCR method we used for pMADMa screening. The genomic DNA
was digested with NlaIII and a specifically designed Splinker was
ligated overnight at 16uC. To make the Splinker adaptor, two
synthetic DNA oligonucleotides: TAACCGTTGCTAGGAGA-
GACCGTGGCTGAATGAGACTGGTGTCGACACTAGTG-
GCATG and CCACTAGTGTCGACACCAGTCTCTAATT-
TTTTTTTTCAAAAAAA were annealed. The ligation products
were purified by the Qiagen PCR purification kit and eluted into
30 ml of TE. 1 ml of the sample was used for the first round of
PCR with primers: AACCGTTGCTAGGAGAGACC and
CCGCAGAACTCGGAACCTA. 0.3 ml of the first PCR product
was subjected to the second round of PCR with primers:
GCTGAATGAGACTGGTGTCG and CAGAGGTTGTT-
CGGGCATAG. The final PCR products were analyzed by
electrophoresis, gel-extracted by the Qiagen gel extraction kit, and
analyzed by DNA sequencing.
Converting pMADM transgenes into GT or TG cassettes
To convert pMADMa to MADM-GT or TG,5mg of a plasmid
(pPGK-Flpo-Puro) containing a codon-optimized Flp recombi-
nase gene (Flpo) [52] and the puromycine resistance gene was
introduced into 5 million cells of selected clones via electropora-
tion. We cultured ES cells with 200 mg/ml G418 and 2 mg/ml
puromycine for 48 hours, and ES cell were subsequently cultured
only in the presence of G418 until colonies formed. Individual
G418-resistant clones were analyzed by two genomic PCRs to
specifically detect 59 and 39 parts of pMADMa and identify non-
recombined clones and partially recombined clones (GT or TG
cassette). One PCR used primers GCAACGTGCTGGT-
TATTGTG and CGCCTCAGGACTCTTCCTTT to amplify
,600 bp product for non-recombined pMADMa cassette and
MADM-GT cassette or ,300 bp product for MADM-TG cassette.
Another PCR used primers GAAACTGGGCATGTGGAGAC
and TGAGTTTGGACAAACCACAAC to amplify ,800 bp
product for non-recombined pMADMa cassette and MADM-TG
cassette or ,2.0 kb PCR product for MADM-GT cassette. The
ES cell clones that contained correctly recombined cassettes were
used to generate chimeric mice by injection into C57BL/6
blastocysts.
To convert pMADMb’1 into MADM-GT or TG, 25 mg of one
of the exchange cassette plasmids (ExG or ExT) and 25 mg of
pPGKFLPobpA plasmid (Addgene plasmid 13793) [52] were
introduced into the selected ES cells (,5610
6 cells). We cultured
the ES cells without selection for 72 hours and then applied
hygromycin (120 mg/ml) for one week. Individual hygromycin-
resistant clones in 96-well plates were divided into five replicas:
two for stock, one for lacZ staining, and two for genomic DNA
preparation. To detect the FRT5/FRT mediated site-specific
recombination events, we used PCR with primers: CTATGCCC-
GAACAACCTCTG and GGGCGTACTTGGCATATGAT to
amplify the junction containing FRT5. This PCR not only
confirmed that the ES clone still contained the MADM transgene,
but also generated different sizes of PCR products for non-
recombined (510 bp) and recombined (550 bp) clones. The PCR
products were analyzed by electrophoresis on a 2% agarose gel.
Site-specific recombination was confirmed by additional PCR
primer sets that specifically amplify the newly formed junctions at
FRT5 (59 of the transgene): CTATGCCCGAACAACCTCTG
and TCCCAGTCCTTGCCATTTAG (create a 286 bp product)
and FRT (39 of the transgene): AAGCATCAACGACAACAACG
and 59- CGGAATACCACTGAAATTGG (create a 200 bp
product). The ES cell clones that contained correctly recombined
cassettes were used to generate chimeric mice by injection into
C57BL/6 blastocysts. The chimeras were directly crossed to a
QC31o integrase mouse line (Jackson laboratory, stock# 007670)
[52] to remove the pPGK-Hyg-pA cassette from the genome in the
next generation.
Tissue processing, immunohistochemistry and imaging
Tissues were processed according to previously described
procedures [10,11]. Neither tdT nor GFP required immunostaining
for visualization. Although the majority of the data presented in the
paper were obtained from unstained tissue sections, sections can be
immunostained for better signal preservation according to previously
published methods [11] using the following primary antibodies:
chicken anti-GFP (1:500; Aves Labs), goat anti-MYC (1:200; Novus;
the best results are obtained if antibody is pre-absorbed with fixed,
finely minced, wild-type brain according to the previously described
procedure [33]), rabbit anti-DsRed (1:1000; Clontech), or rabbit anti-
LacZ (1:500; MP Biomedicals (previously Cappel) Cat.
No. 0855976). Secondary antibodies (donkey anti-chicken FITC,
donkey anti-rabbit Cy3 and donkey anti-goat Cy3 from Jackson
ImmunoResearch), were used at 1:200 dilution. In some cases,
sections were also stained with DAPI. Sections were imaged with a
Nikon CCD camera or a confocal microscope (Zeiss 510).
Genotyping
Mouse DNA was extracted and genotyping PCR performed as
described previously [36].
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(CTATGCCCGAACAACCTCTG), KM6 (ATCATATGCCA-
AGTACGCCC), KM7 (GGGGTCGATCTTGTCAGTCT) and
KM8 (TTGCGTTGCAATTTTCTGAG). These primers ampli-
fy a 512 bp transgene fragment and a 700 bp wt M1 locus
fragment.
For genotyping M10 MADM transgenes, we used primers:
KM1 (GTGCTGCAAGGCGATTAAGT) and KM2 (TTATG-
TAACGCGGAACTCCA). These primers amplify a 211 bp
fragment for either MADM cassette. To distinguish heterozygous
vs. homozygous transgene, we used additional primers KM3
(CATATTCCAAAGCTACCACACACT) and KM4 (ATCATG-
GAGGAGCAGTGGAG), which amplify a 300 bp fragment from
the wt M10 locus.
H11 MADM transgenes (available at The Jackson Laboratory:
MADM-11-GT, stock# 013749 and MADM-11-TG, stock#
013751) were genotyped as described [14], using primers: SH176
(TGGAGGAGGACAAACTGGTCAC), SH177 (TCAATGGG-
CGGGGGTCGTT), SH178 (TTCCCTTTCTGCTTCAT-
CTTGC) according to the genotyping protocol deposited to The
Jackson Laboratory.
For genotyping Rosa26 knock-ins we used primers Rosa4
(TCAATGGGCGGGGGTCGTT), Rosa10 (CTCTGCTGC-
CTCCTGGCTTCT) and Rosa11 (CGAGGCGGATCACAAG-
CAATA). These primers amplify a 250 bp knock-in fragment and
a 330 bp wt Rosa26 locus fragment.
For genotyping TRE-KZ, we used primers Tau1
(GGTGGCAAGGTGCAGATAAT) and Tau2 (CAGCTTGTG-
GGTTTCGATCT) to amplify a 315 bp tau fragment. We
combined them with primers IMR0015 (CAAATGTTGCTT-
GTCTGGTG) and IMR0016 (GTCAGTCGAGTGCACAG-
TTT) to amplify a 200 bp internal control fragment.
For genotyping Foxg1
tTA, we used primers Ling40 (TCTGC-
ACCTTGGTGATCAAA) and Ling57 (ATCGCGATGGAG-
CAAAAGTA) to amplify a 270-bp fragment of tTA. We
combined them with primers Globin1 (CCAATCTGCTCACA-
CAGGATAGAGAGGGCAGG) and Globin2 (CCTTGAGGC-
TGTCCAAGTGATTCAGGCCATCG) to amplify a 500 bp
internal control fragment.
For genotyping Cre transgenes, we used Foxg1-Cre-A
(CACCCTGTTACGTATAGCCG) and Foxg1-Cre-B (GAGT-
CATCCTTAGCGCCGTA) to amplify a 300 bp transgene
fragment and internal Globin primers as described for tTA
genotyping to amplify the internal control.
Genotyping for the presence of the neomycin resistance gene
(Neo) was performed using primers IMR3742 (GTGAGCTG-
CACTTCCAGAAG), IMR3743 (GACTTTCGGCATGTGA-
AATG), IMR013 (CTTGGGTGGAGAGGCTATTC) and
IMR014 (AGGTGAGATGACAGGAGATC). These primers
produce a 280 bp Neo band and a 180 bp wt band.
Mouse maintenance and crosses
All mice were kept in a mixed background. All mouse lines
contained some 129 and CD1 strain backgrounds, and some
additionally contained C57Bl/6 and FVB. We preferred to keep
mice with as much CD1 background as possible to increase
fecundity.
We kept GT and TG stocks separately from each other. This
approach prevents mixing up the stocks and allowed us to use the same
PCR for genotyping either stock using the common pairs of primers.
Other transgenes were crossed into one of the MADM cassette alleles.
Once a Nestin-Cre or Hprt
Cre line is crossed into one of the MADM
cassette strains, the loxP-flanked (floxed) Neo is removed in the germline.
Therefore any double positive animal of this type will transmit to its
progeny the MADM cassette with removed Neo. The MADM cassette
alleles were then usually homozygosed during maintenance to obviate
the need for genotyping for that allele. For example, to generate the
experimental animals R26
TG/GT;Nestin-Cre
+/2;TRE-KZ
+/2,w ew o u l d
create two lines: R26
GT/GT and R26
TG/TG;Nestin-Cre
+/2;TRE-KZ
+/2.
The first line, as well as other MADM-cassette lines, were usually kept
homozygous (no genotyping required). In the case of R26
GT/GT only,
some homozygous males show decreased fertility, so from time to time
a homozygous female was crossed to a CD1 wt male, and after that the
homozygous stock was reestablished by crossing heterozygous mice to
each other. The second line was created by sequentially introducing
Nestin-Cre and TRE-KZ transgenes into R26
TG mice. After the
triple-transgenic mice R26
TG/+;Nestin-Cre
+/2;TRE-KZ
+/2 were
created, they were crossed to R26
TG/TG to create R26
TG/TG;
Nestin-Cre
+/2;TRE-KZ
+/2. These mice were maintained by crossing
to R26
TG/TG homozygous stock and genotyping only for the presence
of Cre and tau.
All GG and TT alleles were generated by Cre-mediated
interchromosomal recombination and were detected by screening
tail samples for expression of GFP or tdT under the fluorescence
microscope. In addition, under UV light, these animals appeared
uniformly green and red, respectively. All GG and TT alleles had
lost the floxed Neo from the intron as confirmed by Neo PCR (see
Genotyping).
Hprt
Cre is located on the X chromosome [19]. If maximal level of
recombination is desired, it is recommended to use males for
phenotypic analysis (Hprt
Cre/Y as opposed Hprt
Cre/+). In females,
due to the random X inactivation, only roughly half of the cells
have the active Hprt
Cre allele.
Reagent availability
The DNA constructs described in this paper will be deposited to
Addgene. We will also deposit the following lines to The Jackson
Laboratory; R26
GT (stock# 017912), R26
TG (stock# 017921),
R26
TT (stock# 017922), R26
G-tTA2 (stock# 017909), Miya10
GT
(stock# 017923), and Miya10
TG (stock# 017932). Note that we
have already deposited the following lines to The Jackson
Laboratory: Rosa26
GG (also called MADM-GG; stock# 006053)
[10], Hipp11
GT (also called MADM-11
GT; stock# 013749), and
Hipp11
TG (also called, MADM-11
TG; stock# 013751) [14].
Whereas the GT and TG mice can be used for MADM analysis
of genes located on those specific chromosomes, GG and TT mice
express high-level green or red fluorescence proteins globally and
can be used, for example, as tissue donors in transplantation or
chimeragenesis experiments.
Supporting Information
Figure S1 Loci and alleles used in this study. A) Miya1
(M1) on Chr. 1; B) Rosa26 (R26) on Chr. 6; C) Miya10 (M10) on
Chr. 10 and D) Hipp11 (H11) on Chr. 11. Panel D is modified
after [14], where H11
GT and H11
TG were referred to as MADM-
11
GT and MADM-11
TG, respectively. The loxP-flanked (floxed) Neo
in any of the alleles above is converted into a single wild-type loxP
site after the allele is crossed to a germline-expressed Cre transgene
(Nestin-Cre or Hprt
Cre). All GG and TT alleles described here were
created by Cre-mediated interchromosomal recombination in
meiosis and have lost the floxed Neo. The previously described
R26
GG allele (also referred to as MADM-GG), which was created by
targeted knock-in, contains the floxed Neo in the intron [10].
(TIF)
Figure S2 A scheme for generation of translocations and
aneuploidy using MADM. A) A cell containing Cre and two
non-homologous chromosomes with reciprocal cassettes in the
Extensions of MADM
PLoS ONE | www.plosone.org 13 March 2012 | Volume 7 | Issue 3 | e33332same orientation, e.g., Chr. 6 and Chr. 10, can generate cells
containing the reciprocal translocation or aneuploidy. B) A cell
containing Cre and two non-homologous chromosomes with
reciprocal cassettes in the opposite orientation, e.g., Chr. 10 and
Chr. 11, can generate cells with acentric and dicentric chromo-
somes and aneuploidy. In this case, change in labeling and
genotype could result from the loss of acentric or dicentric
chromosomes during cell division.
(TIF)
Figure S3 A built-in TRE reporter within the G-TET
allele is mostly silent. A) With the aim of simplifying the use of
MADM-Tet by minimizing the number of transgenes that need to
be combined in a single animal, we generated another version of
G-tTA2 that had a built-in TRE reporter (TRE-tdT-3Myc), which
we call G-TET (Figure S1B). In the G-TET construct, we flanked
the TRE expression unit with pairs of insulators to decrease the
tTA-independent leakiness of TRE. This leakiness was initially
observed in transient transfection experiments with a plasmid
containing a pCA-containing unit preceding the TRE unit
(pBT267). This leakiness was significantly decreased when
insulators were inserted to flank the TRE (pBT268, data not
shown). We tested the G-TET construct in vivo by creating a knock-
in mouse in Rosa26 and then by creating a triple-transgenic mouse:
R26
TG/G-TET;Nestin-Cre
+/2. We observed only GFP expression.
The panel shows an epifluorescence image of a cortical tissue
section from the genotype indicated on top, stained with anti-GFP
and anti-Myc antibodies, and DAPI. B) To test for TRE activation
in the brain, we crossed R26
G-TET to Foxg1
tTA knock-in allele,
which expresses tTA strongly in the mouse forebrain [53] and is
capable of activating a TRE line previously generated in our lab by
random transgenesis (TRE-SG-T; [33]). However, when G-TET
was crossed to Foxg1
tTA, the activation was observed only in a
subset of vomeronasal receptor neurons in a tTA-dependent
manner. The panel shows native tdT fluorescence in forebrain
tissue sections with genotypes indicated on top. Thus, we conclude
that our TRE-tdT-3Myc, which is part of G-TET, cannot be
activated by tTA in most cells of the forebrain.
(TIF)
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